Biotechnology
-
Daily Stock Watch: Is Kymera a Buy?
Biotech outfit Kymera Therapeutics (NASDAQ: KYMR) is heading upwards on the back of positive clinical trial news. But is KYMR stock a good investment?
-
Is Ginkgo Bioworks Stock A Good Buy?
The Ginkgo Bioworks (NYSE: DNA) share price is beaten down this year. We look at whether DNA Stock is a good buy.
-
IPO Preview: SAVU, KWE, BFAI
The upcoming IPOs in focus this week include lab-grown organ outfit BioLife4D Corp, non-lethal weapons developer Kwesst and AI healthcare...
-
Daily Stock Watch: Is Veeva Systems a Buy?
Shares of Veeva Systems Inc (NYSE: VEEV) are markedly lower on Friday on the back of earnings disappointment. But with few competitors and a...
-
Daily Stock Watch: HZNP Climbs on Buyout Rumblings
Horizon Therapeutics (NASDAQ: HZNP) has seen its share price leap on the back of M&A news, but does that mean HZNP stock is a good investment?
-
Daily Stock Watch: ISEE Stock's Eye Watering Rise
Iveric Bio Inc (NASDAQ: ISEE) has seen its share price leap following a new FDA designation. However, with good news for a key competitor emerging...
-
IPO Outlook: GNLX, BFAI
The IPOs to look out for this week include cancer treatment outfit Genelux Corporation and medicine development and AI specialist BullFrog AI.
-
Daily Stock Watch: Biotech Stock BLI Rises 20%
Berkeley Lights (NASDAQ: BLI) released Q3 earnings with record recurring revenues, leading the BLI share price to rise 20%.
-
Are Biotech Penny Stocks Worth Investing In?
What can biotech penny stocks do for you? While investors might be attracted by the potential for outsize returns, there are serious risks to...
-
IPO Outlook: BFAI, SNAL, ACRV
The IPOs to look out for this week include medicine development and AI specialist BullFrog AI, game developer Snail and biopharma outfit Acrivon...
-
Daily Stock Watch: Aurinia Pharmaceuticals Slashes Sales Forecast
Aurinia Pharmaceuticals (NASDAQ: AUPH) has seen its share price fall yet further as Q3 results included a cut in sales forecast. But is AUPH stock...
-
Daily Stock Watch: ESSA Pharma Dips on Trial Suspension
Though ESSA Pharma Inc (NASDAQ: EPIX) saw its share price soar last week on strong pre-clinical news, a trial hiccup is giving investors jitters....
-
IPO Outlook: MBLY, ASPI, INTS
The coming week's IPOs could include offerings from Mobileye Global (NASDAQ: MBLY), ASP Isotopes (NASDAQ: ASPI) and Intensity Therapeutics (NASDAQ:...
-
Daily Stock Watch: IMUX Stock Tumbles on Placebo Performance
Immunic Inc (NASDAQ: IMUX) has lost three quarters of its share price after investors were left unimpressed with clinical trial data. But is IMUX...
-
IPO Outlook: ALPX, BMR, ASPI, INTS, PRME
The coming week's IPOs could include offerings from Alopexx (NASDAQ: ALPX), Beamr Imaging (NASDAQ: BMR), ASP Isotopes (NASDAQ: ASPI), Intensity...
-
Daily Stock Watch: MIST Stock Falters Despite Trial Success
One stock heading lower at the start of this week is biopharma outfit Milestone Pharmaceuticals (NASDAQ: MIST). But is MIST stock a good investment?
